Loren Data's SAM Daily™

FBO DAILY ISSUE OF APRIL 15, 2004 FBO #0871
SOLICITATION NOTICE

B -- Continued Collaboration of the Maternal Cohort Study of the Nurses

Notice Date

4/13/2004
 

Notice Type

Solicitation Notice
 

NAICS

541990 — All Other Professional, Scientific, and Technical Services
 

Contracting Office

Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
 

ZIP Code

20852
 

Solicitation Number

NCI-40055-NG
 

Response Due

4/28/2004
 

Archive Date

5/13/2004
 

Point of Contact

Malinda Holdcraft, Purchasing Agent, Phone (301) 402-4509, Fax (301) 402-4513, - Renita Smith, Contract Specialist, Phone 301-496-8612, Fax 301-480-0241,
 

E-Mail Address

holdcram@exchange.nih.gov, rs442i@nih.gov
 

Description

The National Cancer Institute (NCI), Basic Research Laboratory (BRL) Center for Cancer Research (CCR), plans to propose a sole source contract with Brigham and Women's Hospital, Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115 for the services to develop documentation of algorithms for the re-coding of data from "Maternal cohort study of the Nurses." The North American Industry Classification System Code is 541990 and the business size standard is $6.0M. The supplies and services herein are being procured in accordance with the simplified acquisition procedures authorized by FAR Part 13. The overall purpose of this procurement is to develop documentation of algorithms related to exposures in utero, in infancy, or early childhood will be examined in relation to recognized risk factors for women's cancers. Mothers of the women (nurse daughters) have reported information about prenatal, postnatal, and early childhood events in a retrospective fashion and the maternal data are linked to two ongoing, large-scale prospective cohort studies, known as the Nurses' Health study I and II, including 40,000 nurses, who have reported data on recognized risk factors for cancer and who are being followed for diagnosis of incident cancers as well as mortality. Maternal study data are also linked to data on risk factors such as age at menarche and adult height and obesity, which have been collected in the ongoing Nurses' Health Studies. The results of the data documentation will lead to the data analysis of the Maternal Cohort Study, which will contribute to NCI's understanding of the potential role of birth weight and length and of infant feeding, i.e. early life exposures, on age at menarche and adult height in order to determine whether early life exposures are related to adult risk factors for cancer and potentially link critical periods of exposures for cancer in a woman's life cycle. The overall objective is to determine whether fetal and early childhood exposures are related to risk factors for adult cancers in women, and to develop documentation of the recoding of major early life exposures such as gestational age and infant feeding from the Maternal Cohort Study; perform edit checks and assess the internal validity of the newly coded items for subsequent analysis of the data. Period of Performance: May 14, 2004 - October 14, 2005. The collaboration between Brigham and Woman's Hospital and NCI began in 1999. Dr. Michels is the co-Principal Investigator on the Maternal Cohort Study and is a member of the original team. She is responsible for testing specific hypothesis on the Maternal Cohort study, and has successfully maintained follow-up of the nurse daughters, once every two (2) years. The nurse daughters are part of the Nurses Health Study I and II, who have been loyal participants with a high response rate of 95% over time. The Brigham and Women's Hospital, Channing Laboratory, is the only source known to the NCI that is familiar with the original files from which the subset of data have been taken. Changing coding teams at this time would interrupt the interpretation of the study objectives. This is not a request for competitive quotation. However, if any interested party believes it can perform the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other furnished information must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform this requirement. Capability statements must be received in the contracting office by 1:00 PM EST, April 28, 2004. If you have any questions they must be submitted in writing to Malinda Holdcraft, Purchasing Agent, at holdcram@exchange.nih.gov or by fax 301-402-4513. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
 

Place of Performance

Address: NIH/NCI

Zip Code: 28952

Country: USA
 

Record

SN00564529-W 20040415/040413211810 (fbodaily.com)
 

Source

FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |